Literature DB >> 3456456

Characterization of human neuroblastoma cell lines established before and after therapy.

C P Reynolds, J L Biedler, B A Spengler, D A Reynolds, R A Ross, E P Frenkel, R G Smith.   

Abstract

Six new cell lines have been established from human neuroblastomas. Cell line SMS-KAN, from primary tumor before therapy, and line SMS-KANR, from bone marrow after chemotherapy and radiotherapy, were established from the same patient. Cell lines SMS-KCN (from primary tumor before any therapy) and SMS-KCNR (from bone marrow after chemotherapy) were established from another patient. Two other lines (SMS-MSN and SMS-SAN) were established from different patients before any therapy was given. Cell lines established from recurrent disease after chemotherapy (SMS-KANR and SMS-KCNR) had significantly shorter doubling times and increased plating efficiencies compared to those of cell lines derived from the same patient before chemotherapy (SMS-KAN and SMS-KCN). All cell lines contained tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and dopamine-beta-hydroxylase. Measurable amounts of choline acetyltransferase were also detected in SMS-KAN and SMS-KANR. Karyotype analysis showed all cell lines except SMS-MSN to be pseudodiploid with modal numbers of 46 and deletions of the short arm of chromosome 1; SMS-MSN had a modal number of 57-58 chromosomes. All cell lines had double-minute chromosomes, except SMS-KANR, which had abnormally banding regions. These new cell lines provide in vitro models of neuroblastoma suitable for the study of differences in neuroblastoma cell populations before chemotherapy as compared to the cell populations that proliferate after therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456456

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  40 in total

1.  Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays.

Authors:  Christos Sotiriou; Chand Khanna; Amir A Jazaeri; David Petersen; Edison T Liu
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

2.  Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.

Authors:  Hua Fang; Theresa M Harned; Ondrej Kalous; Vanessa Maldonado; Yves A DeClerck; C Patrick Reynolds
Journal:  Clin Cancer Res       Date:  2011-09-20       Impact factor: 12.531

3.  Ligand-mimicking receptor variant discloses binding and activation mode of prolactin-releasing peptide.

Authors:  Daniel Rathmann; Diana Lindner; Stephanie H DeLuca; Kristian W Kaufmann; Jens Meiler; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

4.  N-myc amplification and its relationship to experimental therapy.

Authors:  A Livingstone; R J Mairs
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

5.  Increased wild-type N-ras activation by neurofibromin down-regulation increases human neuroblastoma stem cell malignancy.

Authors:  Dan Han; Barbara A Spengler; Robert A Ross
Journal:  Genes Cancer       Date:  2011-11

6.  Calcium ionophore-induced degradation of neurofilament and cell death in MSN neuroblastoma cells.

Authors:  S O Chan; E Runko; K Anyane-Yeboa; L Ko; F C Chiu
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

7.  Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms.

Authors:  N Kalcheva; J Albala; K O'Guin; H Rubino; C Garner; B Shafit-Zagardo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.

Authors:  V Feyles; W T Dixon; L K Sikora; R C McGarry; L M Jerry
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  Expression of myc and ras oncogenes in two newly established neuroblastoma cell lines.

Authors:  F Csaikl; L Müllauer; U Csaikl; M Vetterlein
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

10.  Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress.

Authors:  Patricia Ferrera; Octavio Mercado-Gómez; Martín Silva-Aguilar; Mahara Valverde; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-02-21       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.